New Findings on Rare Mucinous Ovarian Cancer May Change Tx New Findings on Rare Mucinous Ovarian Cancer May Change Tx
A global study of the microscopic patterns of cell growth in samples taken from women with this rare form of ovarian cancer may lead to treatment changes for some.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 21, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
T-cells can be directed to treat a variety of ovarian cancers
Scientists have discovered a receptor-protein that is expressed on the surface of different types of ovarian tumor cells, including clear cell and mucinous ovarian tumors, two of the most aggressive subtypes of the disease. The protein is not found on non-ovarian healthy tissues in adult women, meaning that this protein could represent a highly specific therapeutic target in a range of ovarian tumors. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 28, 2016 Category: Science Source Type: news
T-cells can be directed to treat a variety of ovarian cancers
( < i > The Wistar Institute < /i > ) Scientists at The Wistar Institute have discovered a receptor-protein that is expressed on the surface of different types of ovarian tumor cells, including clear cell and mucinous ovarian tumors, two of the most aggressive subtypes of the disease. The protein is not found on non-ovarian healthy tissues in adult women, meaning that this protein could represent a highly specific therapeutic target in a range of ovarian tumors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 28, 2016 Category: Global & Universal Source Type: news
Answer revealed to this top-missed USMLE Step 2 question
Getting ready for the United States Medical Licensing Examination® (USMLE®) Step 2 is no easy feat, but we’re sharing expert insights to help give you a leg up. Take a look at the exclusive scoop on this month’s most-missed USMLE Step 2 test prep question. Think you have what it takes to rise above your peers? Test your USMLE knowledge, and view an expert video explanation of the answer from Kaplan Medical.
Once you’ve got this question under your belt, be sure to test your knowledge with other posts in this series.
Ready. Set. Go.
This month’s question that stumped most students:
A 42-year-old woman come...
Source: AMA Wire - May 25, 2016 Category: Journals (General) Authors: Troy Parks Source Type: news
Scientists find genetic variants key to understanding origins of ovarian cancer
New research is bringing the origins of ovarian cancer into sharper focus.The study highlights the discovery of three genetic variants associated with mucinous ovarian carcinomas (MOCs), offering the first evidence of genetic susceptibility in this type of ovarian cancer. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 15, 2015 Category: Science Source Type: news
Scientists find genetic variants key to understanding origins of ovarian cancer
(University of Southern California - Health Sciences) New research by an international team including Keck Medicine of USC scientists is bringing the origins of ovarian cancer into sharper focus.The study, published online June 15 in the peer-reviewed journal Nature Genetics, highlights the discovery of three genetic variants associated with mucinous ovarian carcinomas (MOCs), offering the first evidence of genetic susceptibility in this type of ovarian cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2015 Category: Cancer & Oncology Source Type: news
MD Anderson's David M. Gershenson, MD, Receives IGCS's Award for Excellence in Gynecologic Oncology
For his myriad clinical, organizational and scientific accomplishments in the field of gynecologic oncology and the health and well-being of women, David M. Gershenson, M.D. has been recognized with the International Gynecology Cancer Society's (IGCS) Award of Excellence.
Gershenson, professor and past chair of the Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center, received the award at the IGCS's 15th Biennial Meeting in Melbourne, Australia. William J. Hoskins, MD., of Memorial Sloan Kettering, also was honored with the distinction.The IGCS is a not-for-prof...
Source: M. D. Anderson Cancer Center - News Releases - November 10, 2014 Category: Cancer & Oncology Source Type: news
